By demonstrating leukemic engraftment potential upon xenotransplantation, the leukemia-initiating nature of AML-derived CD34+CD38− cells expressing these aberrancies has been confirmed [21, 22]. This evidence concerns the gene CD38 and acute myeloid leukemia.